Novartis (RNAI Research and Development Portfolio) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
1
Novartis (RNAI Research and Development Portfolio) General Information
Description
Provider of research and development services to the pharmaceutical industry. The company's services include computer modeling and simulation, clinical development, clinical trials and drug discovery for disorders ranging from cancer to degenerative diseases.
Contact Information
Corporate Office
- Lichtstrasse 35
- 4056 Basel
- Switzerland
Corporate Office
- Lichtstrasse 35
- 4056 Basel
- Switzerland
Novartis (RNAI Research and Development Portfolio) Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Novartis (RNAI Research and Development Portfolio) Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
Novartis (RNAI Research and Development Portfolio) FAQs
-
Where is Novartis (RNAI Research and Development Portfolio) headquartered?
Novartis (RNAI Research and Development Portfolio) is headquartered in Basel, Switzerland.
-
What industry is Novartis (RNAI Research and Development Portfolio) in?
Novartis (RNAI Research and Development Portfolio)’s primary industry is Biotechnology.
-
Is Novartis (RNAI Research and Development Portfolio) a private or public company?
Novartis (RNAI Research and Development Portfolio) is a Private company.
-
What is the current valuation of Novartis (RNAI Research and Development Portfolio)?
The current valuation of Novartis (RNAI Research and Development Portfolio) is
. -
What is Novartis (RNAI Research and Development Portfolio)’s current revenue?
The current revenue for Novartis (RNAI Research and Development Portfolio) is
. -
Who are Novartis (RNAI Research and Development Portfolio)’s investors?
Novartis has invested in Novartis (RNAI Research and Development Portfolio).
-
When was Novartis (RNAI Research and Development Portfolio) acquired?
Novartis (RNAI Research and Development Portfolio) was acquired on 05-Mar-2015.
-
Who acquired Novartis (RNAI Research and Development Portfolio)?
Novartis (RNAI Research and Development Portfolio) was acquired by Arrowhead Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »